stoxline Quote Chart Rank Option Currency Glossary
  
Schrödinger, Inc. (SDGR)
18.78  -0.17 (-0.9%)    06-21 16:00
Open: 18.83
High: 19
Volume: 1,113,097
  
Pre. Close: 18.95
Low: 18.6
Market Cap: 1,365(M)
Technical analysis
2024-06-21 4:55:12 PM
Short term     
Mid term     
Targets 6-month :  25.24 1-year :  27.41
Resists First :  21.6 Second :  23.46
Pivot price 21.05
Supports First :  18.6 Second :  15.47
MAs MA(5) :  19.51 MA(20) :  21.24
MA(100) :  25.1 MA(250) :  30.61
MACD MACD :  -1.1 Signal :  -0.8
%K %D K(14,3) :  3.1 D(3) :  2.9
RSI RSI(14): 30
52-week High :  59.24 Low :  18.6
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SDGR ] has closed above bottom band by 7.6%. Bollinger Bands are 17.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 19.12 - 19.31 19.31 - 19.42
Low: 18.21 - 18.45 18.45 - 18.59
Close: 18.5 - 18.9 18.9 - 19.13
Company Description

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Headline News

Thu, 20 Jun 2024
Schrodinger Becomes Oversold (SDGR) - Nasdaq

Fri, 14 Jun 2024
5763 Shares in Schrödinger, Inc. (NASDAQ:SDGR) Bought by Cim Investment Management Inc. - Defense World

Wed, 12 Jun 2024
We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right - Simply Wall St

Tue, 07 May 2024
Schrödinger: More Pharmaceutical Than Software (NASDAQ:SDGR) - Seeking Alpha

Wed, 01 May 2024
Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript - Seeking Alpha

Wed, 01 May 2024
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 64 (M)
Shares Float 62 (M)
Held by Insiders 2.3 (%)
Held by Institutions 94.5 (%)
Shares Short 7,890 (K)
Shares Short P.Month 6,420 (K)
Stock Financials
EPS -2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.07
Profit Margin -76 %
Operating Margin -184.3 %
Return on Assets (ttm) -17 %
Return on Equity (ttm) -26 %
Qtrly Rev. Growth -43.5 %
Gross Profit (p.s.) 0
Sales Per Share 2.96
EBITDA (p.s.) -3.3
Qtrly Earnings Growth 0 %
Operating Cash Flow -145 (M)
Levered Free Cash Flow -102 (M)
Stock Valuations
PE Ratio -9.4
PEG Ratio 2
Price to Book value 2.65
Price to Sales 6.32
Price to Cash Flow -8.24
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android